Low-dose rituximab is efficacious in refractory idiopathic inflammatory myopathies
Year: 2022
Type: article
Study design: Observational Study
Source: Rheumatology
Authors: Ramya Janardana, S N Amin, Liza Rajasekhar, Benzeeta Pinto, Chanakya Kodishala, Sumithra Selvam, Vineeta Shobha
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4292405411
